| Dr Ehab Samir Morcos, MD | |
|
2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368-2205 | |
| (800) 862-9980 | |
| (314) 362-1185 |
| Full Name | Dr Ehab Samir Morcos |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 2 Progress Point Pkwy, O Fallon, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588645345 | NPI | - | NPPES |
| 207269002 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 2003026616 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hshs St Elizabeth's Hospital | O fallon, IL | Hospital |
| Plantation General Hospital | Plantation, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North American Partners In Anesthesia Illinois Llc | 1052576519 | 286 |
| Anesthesia Physician Solutions Of South Florida, Llc | 4688805286 | 220 |
News Archive
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
American women who ate higher amounts of soy during childhood had a 58 percent reduced risk of breast cancer, according to a study published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
"Before Republican budget hawks wield their knife, ... they should take a lesson from their conservative cousins in the United Kingdom: When belt-tightening gets serious, foreign aid should be improved, not gutted," according to an opinion piece in the New Republic written by Thomas Carothers, vice president for studies at the Carnegie Endowment for International Peace.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
› Verified 5 days ago
| Entity Name | North American Partners In Anesthesia Illinois Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699032524 PECOS PAC ID: 1052576519 Enrollment ID: O20120706000534 |
News Archive
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
American women who ate higher amounts of soy during childhood had a 58 percent reduced risk of breast cancer, according to a study published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
"Before Republican budget hawks wield their knife, ... they should take a lesson from their conservative cousins in the United Kingdom: When belt-tightening gets serious, foreign aid should be improved, not gutted," according to an opinion piece in the New Republic written by Thomas Carothers, vice president for studies at the Carnegie Endowment for International Peace.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
› Verified 5 days ago
| Entity Name | Resource Anesthesiology Associates Of Il Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750347829 PECOS PAC ID: 5698006641 Enrollment ID: O20191007000960 |
News Archive
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
American women who ate higher amounts of soy during childhood had a 58 percent reduced risk of breast cancer, according to a study published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
"Before Republican budget hawks wield their knife, ... they should take a lesson from their conservative cousins in the United Kingdom: When belt-tightening gets serious, foreign aid should be improved, not gutted," according to an opinion piece in the New Republic written by Thomas Carothers, vice president for studies at the Carnegie Endowment for International Peace.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ehab Samir Morcos, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (800) 862-9980 | Dr Ehab Samir Morcos, MD 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368-2205 Ph: (800) 862-9980 |
News Archive
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
American women who ate higher amounts of soy during childhood had a 58 percent reduced risk of breast cancer, according to a study published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
"Before Republican budget hawks wield their knife, ... they should take a lesson from their conservative cousins in the United Kingdom: When belt-tightening gets serious, foreign aid should be improved, not gutted," according to an opinion piece in the New Republic written by Thomas Carothers, vice president for studies at the Carnegie Endowment for International Peace.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
› Verified 5 days ago
Dr. Chakrapol Lattanand, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368 Phone: 800-862-9980 Fax: 314-362-1185 | |
Dr. John Jacob Long, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368 Phone: 800-862-9980 Fax: 314-362-1185 | |
Dr. Sunita Dharmavarapu, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2 Progress Point Ct, O Fallon, MO 63368 Phone: 314-286-1050 Fax: 314-344-1138 | |
Dr. David A Friedman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Ct, O Fallon, MO 63368 Phone: 636-344-1170 Fax: 636-344-1138 | |
Vivek K Manchanda, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4122 Keaton Crossing Blvd, Suite 102, O Fallon, MO 63368 Phone: 636-329-9077 Fax: 636-329-9076 | |
Dr. Jessica Lauren Sanford, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368 Phone: 800-862-9980 Fax: 314-362-1185 | |
Dr. Isabella Rossi Riordan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368 Phone: 800-862-9980 Fax: 314-362-1185 |